The role of T-cell subsets in the response to anti-CD3 monoclonal antibodies

Barbara Finck(Coherus BioSciences (United States)), David Wofsy(University of California, San Francisco), Nancy Carteron(United States Department of Veterans Affairs), Christianne Yung(University of California, Los Angeles)
Clinical Immunology and Immunopathology
December 1, 1992
10.1016/0090-1229(92)90152-e
Cited by 6

Related Papers

A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
|New England Journal of Medicine|2000|1.8k
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
|The Lancet|2000|1.5k
The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|840
Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes
|Arthritis & Rheumatism|2002|733
Long‐term efficacy and safety of etanercept in children with polyarticular‐course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open‐label, extended‐treatment trial
|Arthritis & Rheumatism|2003|256